Market View: Boeing’s Comeback, India’s Trade Breakthrough and Big Tech’s Next Test
From aircraft crises to AI cables and a surprise trade pact, markets are being pulled in very different directions at once. Boeing’s earnings revive hopes of a turnaround as deliveries improve after y...
28 Jan 24min
Money and Me: Is Cash Quietly Making You Poorer?
Michelle Martin asks if falling interest rates are changing the maths for Singapore’s savers who love hoarding cash. With billions still parked in T-Bills and money-market funds, investors now face a ...
27 Jan 18min
Market View: Power Cuts in the US, $5k Gold and the Great AI Pivot
A brutal US winter storm knocks out power, freezes gas production and sends energy prices - and energy stocks - sharply higher. Gold smashes through US$5,000 an ounce as the US dollar weakens, pushing...
27 Jan 24min
Money and Me: The Boring Maths Behind Extraordinary Wealth
Today Michelle picks up a thought-provoking book by a serial British entrepreneur Gary Ashworth. The book unpacks a simple framework; what if becoming rich wasn’t about genius or luck - but about repe...
26 Jan 22min
Market View: Banks Bounce, Bears Circle, and Big Tech Braces for Earnings
United Overseas Bank has surged back into favour as investors reassess Singapore’s banking sector after months of caution. Michelle Martin and Ryan Huang unpack why UOB’s provisioning fears have eased...
26 Jan 24min
Money and Me: Why no sell-off? How to look beyond the Mag 7, and why cash is really not king now
Markets are rattled by geopolitics - but panic is rarely a strategy. From US military action in Venezuela to tensions over Greenland, investors are questioning whether uncertainty now warrants a shift...
23 Jan 19min
Market View: Why Intel sold-off, P&G’s silk diaper strategy and Inflation Risks for Investors
Intel beats earnings - but supply bottlenecks spook markets. We unpack why Intel sold off despite stronger revenue, and what supply constraints signal for the chip cycle. From semiconductors to staple...
23 Jan 22min
Market View: Cancer Profits, Greenland Politics, Johnson & Johnson, L’Oréal, Lululemon, Ryanair, City Developments Limited, Hongkong Land, Singtel, Thai Beverage
A 140-year-old healthcare giant shows it can still grow, as Johnson & Johnson beats earnings expectations and doubles down on its ambition to lead the global fight against cancer. On geopolitics, mark...
22 Jan 21min
